Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus

Descripción del Articulo

Objective: To determine the Prevalence of hyperhomocysteinemia in patients with type 2 diabetes mellitus in the Endocrinology Service of Arzobispo Loayza National Hospital.   Materials and methods: The study is a cross-sectional, descriptive and analytical assessment perfo...

Descripción completa

Detalles Bibliográficos
Autores: Cárdenas Gamarra, Giuliana, Hurtado Helard, Manrique, Armas Rodríguez, Víctoria, Álvarez Balbín, Vladimir Ronald, Juárez Carbajal, Ronald
Formato: artículo
Fecha de Publicación:2010
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:ojs.pkp.sfu.ca:article/1416
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/1416
Nivel de acceso:acceso abierto
Materia:Folic acid
homocysteine
diabetes mellitus
id REVCMP_534b0b87179356169e48dc6eeaf24bb2
oai_identifier_str oai:ojs.pkp.sfu.ca:article/1416
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitusPrevalencia de hiperhomocisteinemia en pacientes con Diabetes Mellitus tipo dosCárdenas Gamarra, Giuliana Hurtado Helard, Manrique Armas Rodríguez, Víctoria Álvarez Balbín, Vladimir Ronald Juárez Carbajal, Ronald Folic acidhomocysteinediabetes mellitusObjective: To determine the Prevalence of hyperhomocysteinemia in patients with type 2 diabetes mellitus in the Endocrinology Service of Arzobispo Loayza National Hospital.   Materials and methods: The study is a cross-sectional, descriptive and analytical assessment performed in a sample including 115 patients diagnosed with type 2 diabetes mellitus, aged between 40 and 70 years, in which plasma homocystein, folic acid and vitamin B12 levels were measured using direct chemoluminiscence, and factors associated with homocysteinemia were also assessed in this population. The SPSS software, version 12.0, Student’s t test, and the chi square test were used for variable assessments, with a 95% significance level. .   Results: 15% of patients had hyperhomocysteinemia. No significant correlation was found (p> 0.005) between homocysteine levels and factors associated with diabetes. However, we found a significant correlation (p = 0.013) with age and with folic acid levels (p = 0.001). Twenty-three (23%) and 72% of subjects had elevated vitamin B-12 levels and folic   Conclusion: TThe prevalence of hyperhomocysteinemia is low compared to other studies performed in this population. Homocysteine acts as a risk factor acting independently from metabolic control and from other factors associated with diabetic patients.Objetivo: Determinar la prevalencia de Hiperhomocisteinemia en pacientes con diabetes mellitus tipo 2 que acuden al Servicio de Endocrinología del Hospital Nacional Arzobispo Loayza.   Materiales y métodos: Estudio descriptivo analítico de corte transversal en una muestra de 115 pacientes con diagnóstico de diabetes mellitus tipo 2, con edades entre 40 y 70 años, en quienes se determinaron los niveles de homocisteína plasmática, ácido fólico y vitamina B12 por quimioluminiscencia directa, y los factores asociados a la hiperhomocisteinemia en estos pacientes. Para el análisis de los resultados empleamos el programa SPSS versión 12,0, la prueba de t student y chi cuadrado para la evaluación de las variables, con un nivel de significancia del 95%.   Resultados: El 15% de los pacientes presentaron hiperhomocisteinemia. No se encontró correlación significativa (p>0,005) entre los niveles de homocisteína y los factores asociados a la diabetes. Sin embargo, encontramos correlación significativa (p=0,013) con la edad y con el ácido fólico (p=0,001). El 23% y 72% presentó niveles elevados de vitamina B-12 y ácido fólico, respectivamente por debajo de los valores normales, sin embargo la correlación entre homocisteína y vitamina B-12 no fue significativa (p>0,05).   Conclusión: La prevalencia de hiperhomocisteinemia es baja en comparación a los estudios realizados en esta población. La homocisteína se comporta como un factor de riesgo independiente al control metabólico y factores asociados a los pacientes diabéticos.Colegio Médico del Perú2010-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://amp.cmp.org.pe/index.php/AMP/article/view/1416ACTA MEDICA PERUANA; Vol 27 No 4 (2010); 264-269ACTA MEDICA PERUANA; Vol. 27 Núm. 4 (2010); 264-2691728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/1416/864Copyright (c) 2020 ACTA MEDICA PERUANAinfo:eu-repo/semantics/openAccessoai:ojs.pkp.sfu.ca:article/14162023-07-06T05:59:51Z
dc.title.none.fl_str_mv Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
Prevalencia de hiperhomocisteinemia en pacientes con Diabetes Mellitus tipo dos
title Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
spellingShingle Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
Cárdenas Gamarra, Giuliana
Folic acid
homocysteine
diabetes mellitus
title_short Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
title_full Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
title_fullStr Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
title_full_unstemmed Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
title_sort Prevalence of hyperhomocysteinemia in patients with type II diabetes mellitus
dc.creator.none.fl_str_mv Cárdenas Gamarra, Giuliana
Hurtado Helard, Manrique
Armas Rodríguez, Víctoria
Álvarez Balbín, Vladimir Ronald
Juárez Carbajal, Ronald
author Cárdenas Gamarra, Giuliana
author_facet Cárdenas Gamarra, Giuliana
Hurtado Helard, Manrique
Armas Rodríguez, Víctoria
Álvarez Balbín, Vladimir Ronald
Juárez Carbajal, Ronald
author_role author
author2 Hurtado Helard, Manrique
Armas Rodríguez, Víctoria
Álvarez Balbín, Vladimir Ronald
Juárez Carbajal, Ronald
author2_role author
author
author
author
dc.subject.none.fl_str_mv Folic acid
homocysteine
diabetes mellitus
topic Folic acid
homocysteine
diabetes mellitus
description Objective: To determine the Prevalence of hyperhomocysteinemia in patients with type 2 diabetes mellitus in the Endocrinology Service of Arzobispo Loayza National Hospital.   Materials and methods: The study is a cross-sectional, descriptive and analytical assessment performed in a sample including 115 patients diagnosed with type 2 diabetes mellitus, aged between 40 and 70 years, in which plasma homocystein, folic acid and vitamin B12 levels were measured using direct chemoluminiscence, and factors associated with homocysteinemia were also assessed in this population. The SPSS software, version 12.0, Student’s t test, and the chi square test were used for variable assessments, with a 95% significance level. .   Results: 15% of patients had hyperhomocysteinemia. No significant correlation was found (p> 0.005) between homocysteine levels and factors associated with diabetes. However, we found a significant correlation (p = 0.013) with age and with folic acid levels (p = 0.001). Twenty-three (23%) and 72% of subjects had elevated vitamin B-12 levels and folic   Conclusion: TThe prevalence of hyperhomocysteinemia is low compared to other studies performed in this population. Homocysteine acts as a risk factor acting independently from metabolic control and from other factors associated with diabetic patients.
publishDate 2010
dc.date.none.fl_str_mv 2010-12-30
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1416
url https://amp.cmp.org.pe/index.php/AMP/article/view/1416
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/1416/864
dc.rights.none.fl_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 ACTA MEDICA PERUANA
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol 27 No 4 (2010); 264-269
ACTA MEDICA PERUANA; Vol. 27 Núm. 4 (2010); 264-269
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1816075107170254848
score 13.871978
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).